Integrated DNA Technologies Opens Facility in Belgium

Joseph A. Walder, IDT's founder and CEO, led the grand opening event. He emphasized that Europe is IDT's most important market outside North America, and that IDT has invested in the heart of Europe as part of its long-range strategy to serve the scientific community globally.

"Although our origins are in the U.S., IDT is now just as much a European company as we are an American one," Dr. Walder stressed. "We want researchers in Europe to benefit from IDT's twenty-year commitment to tireless innovation and peerless quality in oligo synthesis," Dr. Walder continued, "and we want to learn from our European colleagues how IDT can best support their research as the science and application of synthetic biology advances.

The state-of-the-art, 2000 square meter research and production site enables IDT to serve customers throughout Europe, the Middle East, and Africa with the same speed and quality that have made IDT the industry leader in the United States.

The Mayor of Leuven, Louis Tobback, was among the many participants at the opening ceremony. He expressed his gratitude for IDT's commitment to Europe and to Belgium. Thanking Dr. Walder in particular, he spoke on behalf of his city and region, "It is an honor that IDT has chosen Leuven for its primary European operation, and we are confident that IDT's investment will benefit Belgium, IDT, and scientists throughout Europe."

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and in pharmaceutical development. IDT's primary business is the manufacturing of custom, synthetic DNA and RNA oligonucleotides.

Related Links:
Integrated DNA Technologies